OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
Sadanandam has classified different tumor types with different prognostic, cell-of-origin/phenotypes and therapeutic responses including pancreatic and colorectal tumours and stroma (in multiple Nature Medicines, Cancer Discovery and other reputed journals). Recently, he has published studies showing how to develop and use clinically relevant biomarker assays in gastrointestinal cancers. He also has shown how personaliseed preclinical trials can be done using in vitro and in vivo models. These pioneering studies are being explored by clinicians and cancer researchers for potential applications for patient benefits
